Literature DB >> 1376354

Characterization and use of monoclonal and polyclonal antibodies against the mouse interferon-gamma receptor.

R D LeClaire1, M Basu, D M Pinson, M L Redick, J S Hunt, P J Zavodny, J L Pace, S W Russell.   

Abstract

To facilitate investigation of its physical and functional properties, 11 monoclonal antibodies (mAbs) and a goat polyclonal IgG specific for the mouse interferon- (IFN-gamma) receptor were characterized and their potential uses studied. Eight of the mAbs interacted with epitopes on the extracellular domain of the receptor, two interacted with epitopes on the intracellular domain, and one interacted with an epitope that could not be localized definitively to either region. Of the 11 mAbs, the majority (8) were IgGs, 2 were IgMs, and 1 was an IgA. Relative avidities of the seven that could be determined ranged from 333 to 0.002 microM-1. Both the polyclonal goat IgG and mAb GR-20 (the latter specific for an epitope in the binding site for IFN-gamma) blocked binding of the ligand and, as expected, prevented induction by IFN-gamma of priming of macrophages for tumor cell killing. None of the other mAbs had an effect despite the fact that GR-22 partially (greater than 50%) blocked binding of IFN-gamma. Neither the polyclonal IgG nor any of the mAbs had an agonist effect. The relative usefulness of the antibodies for immunoprecipitation, immunoblotting, immunoassay, and cell staining with and without prior fixation is described. The results of immunocytochemical staining directly confirmed that the majority of immunologically reactive receptor protein expressed by cells is intracellular. To facilitate use by other investigators, the hybridomas that produce these mAbs will be offered to the American Type Culture Collection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376354     DOI: 10.1002/jlb.51.5.507

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  6 in total

1.  Regulation of IFN-gamma signaling is essential for the cytotoxic activity of CD8(+) T cells.

Authors:  G Z Tau; S N Cowan; J Weisburg; N S Braunstein; P B Rothman
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

2.  IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes.

Authors:  H E Thomas; J L Parker; R D Schreiber; T W Kay
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

3.  CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma.

Authors:  D Mumberg; P A Monach; S Wanderling; M Philip; A Y Toledano; R D Schreiber; H Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

4.  Increased capacity for interleukin-2 synthesis parallels disease progression in mice infected with Leishmania major.

Authors:  F P Heinzel; R M Rerko; A M Hujer; R A Maier
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  Gamma interferon inhibits production of Anti-OspA borreliacidal antibody in vitro.

Authors:  Erik L Munson; Brian K Du Chateau; Jani R Jensen; Steven M Callister; David J DeCoster; Ronald F Schell
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

6.  Regulation of staphylococcal enterotoxin B-elicited nitric oxide production by endothelial cells.

Authors:  R D LeClaire; W M Kell; R A Sadik; M B Downs; G W Parker
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.